Updated: Mar 28

Congratulations to our Scientific Advisor Dr. Matthew Marx. Dr. Marx is co-inventor of the clinical KRAS G12C inhibitor adagrasib, which was recently voted #2 drug of the year, behind only Paxlovid, Pfizer's COVID antiviral drug. We are grateful to be receiving guidance from such a well-distinguished scientist!

Updated: Mar 10

It was a great way to celebrate International Women's Day as Dr. Teri Suzuki presented at the Eureka Institute Conference on March 8, 2022. Her presentation focused on making smart decisions for a successful scientific career as an industry professional. After receiving her PhD in Biochemistry, Dr. Suzuki worked for several companies, including Hoechst and Sanofi, and now serves as the Vice President of Preclinical Biology at Reglagene.

Updated: Mar 2

Last week Reglagene's Director of Operations Michael Abrahamson presented at Destination Startup®. Thank you to Venture Partners at CU Boulder for hosting a great event. We look forward to continue building relationships throughout the Intermountain West. Also, a big thank you to Tech Launch Arizona for all the support.